No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families-Reference-Cited by-同舟云学术

No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families

Published:2006-06 Issue:2 Volume:10 Page:104-115
ISSN:1090-6576
Container-title:Genetic Testing
language:en
Short-container-title:Genetic Testing

Author:

Moisan Anne-Marie¹,Fortin Jessyka¹,Moisan Martine Dumont¹,Samson Carolle¹,Bessette Paul²,Chiquette Jocelyne³,Laframboise Rachel⁴,Lépine Jean⁵,Lespérance Bernard⁶,Pichette Roxane⁶,Plante Marie⁷,Provencher Louise³,Voyer Patricia⁸,Goldgar David⁹,Bridge Peter¹⁰,Simard Jacques¹¹¹

Affiliation:

1. Cancer Genomics Laboratory, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec, and Laval University, Québec.

2. Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke.

3. Centre des maladies du sein Deschènes-Fabia, Hôpital Saint-Sacrement, CHA, Québec

4. Clinical Genetic Division, Centre Hospitalier Universitaire de Québec, and Laval University, Québec.

5. Service of Haemato-Oncology, Centre hospitalier régional de Rimouski, Rimouski.

6. Department of Haemato-Oncology, Hôpital du Sacré-Coeur de Montréal, Montréal.

7. Gynecologic Oncology Division, Hôtel-Dieu de Québec, Centre Hospitalier Universitaire de Québec, and Laval University, Québec.

8. Clinique des maladies du sein, Carrefour de Santé de Jonquière, Jonquière.

9. Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah.

10. Molecular Diagnostic Laboratory, Alberta Children's Hospital, Calgary.

11. Canada Research Chair in Oncogenetics, Department of Anatomy-Physiology, Faculty of Medicine, Laval University, Québec.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical)

Link

http://www.liebertpub.com/doi/pdf/10.1089/gte.2006.10.104

Reference40 articles.

1. Large genomic deletions inactivate the BRCA2 gene in breast cancer families

2. Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges

3. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families

4. The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

5. Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of BRCA1, BRCA2 Gene in Overall Development and Prognosis of Breast Cancer;Breast Cancer: From Bench to Personalized Medicine;2022

2. The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families;Cancers;2021-07-07

3. 5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints;Cancers;2021-06-25

4. BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing;Genes;2021-04-02

5. Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data;PeerJ;2019-11-15